Nanomaterials for Protein Delivery in Anticancer Applications

Area of Science:

• Biotechnology
• Nanomedicine
• Drug Delivery

Background:

• Nanotechnology platforms like nanoparticles, liposomes, dendrimers, and micelles are widely researched for drug delivery.
• Proteins, including therapeutic proteins and nanocarriers for anticancer agents, show significant potential in treating diseases.

Purpose of the Study:

• To review existing nanoparticle delivery systems for proteins.
• To examine intracellular delivery of protein therapeutics for anticancer effects and cancer vaccines.
• To explore current applications of protein delivery in cancer treatment.

Main Methods:

• Review of existing literature on nanoparticle delivery systems.
• Analysis of design strategies, advantages, and limitations of various nanocarriers.
• Examination of intracellular delivery mechanisms for protein therapeutics.

Main Results:

• Nanoparticle systems offer diverse strategies for delivering small molecules and biologics, including proteins.
• Protein therapeutics can be delivered intracellularly for anticancer effects and vaccine development.
• Current applications highlight the potential of protein delivery in oncology.

Conclusions:

• Nanoparticle-based protein delivery holds significant promise for advancing cancer treatment and prevention.
• Further research into intracellular delivery mechanisms can optimize therapeutic outcomes.
• Protein therapeutics represent a versatile class of drugs for nanomedicine applications.